PROCEPT BioRobotics Corp (PRCT)
64.31
+2.57
(+4.16%)
USD |
NASDAQ |
May 03, 16:00
64.28
-0.03
(-0.05%)
After-Hours: 20:00
PROCEPT BioRobotics Cash from Investing (TTM): -21.81M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -21.81M |
| December 31, 2023 | -25.21M |
| September 30, 2023 | -17.36M |
| June 30, 2023 | -13.09M |
| March 31, 2023 | -7.937M |
| Date | Value |
|---|---|
| December 31, 2022 | -2.653M |
| September 30, 2022 | -2.119M |
| June 30, 2022 | -0.716M |
| March 31, 2022 | -0.608M |
| December 31, 2021 | -0.592M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-25.21M
Minimum
Dec 2023
-0.592M
Maximum
Dec 2021
-9.209M
Average
-5.295M
Median
Cash from Investing (TTM) Benchmarks
| Globus Medical Inc | 302.97M |
| Glaukos Corp | -1.456M |
| Integra Lifesciences Holdings Corp | -94.18M |
| Intuitive Surgical Inc | -1.062B |
| Masimo Corp | -81.20M |